VESALIUS MEDICAL TECHNOLOGIES
InactiveVESALIUS MEDICAL TECHNOLOGIES was declared bankrupt on 10-10-2024 (Ondernemingsrechtbank Leuven); the bankruptcy was closed for insufficient assets by judgment of 15-01-2026, published in the Belgian State Gazette on 20-01-2026.
No longer registered with the KBO; last annual accounts for fiscal year 2023.
Signals
Three signals. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2023 was due by 31-01-2024 and was filed on 09-01-2024, 22 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2023
22 d early
← before the deadline
after the deadline →
Financials · fiscal year 2023, micro schema
Equity
€-718k
Total assets
€267k
Net result
€-117k
Working capital
€-81k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Assets €267k
Fixed assets
€265k
Current assets
€2k
Key figures and ratios
EBITDA
€-12k
Cash flow
€-28k
Solvency
-269.4%
Current ratio
0.02
Quick ratio
0.02
Debt / equity
-1.37
ROA
-43.8%
Interest coverage
-0.71
Debt
€985k
Debt ≤ 1 year
€83k
Debt > 1 year
€741k
Filed annual accounts
As filed with the NBB · 2023
Balance sheet
Code2023
Assets
Total assets20/58€267k
Fixed assets21/28€265k
Intangible fixed assets21€265k
Current assets29/58€2k
Amounts receivable within one year40/41€494
Other amounts receivable41€494
Cash at bank and in hand54/58€1k
Equity and liabilities
Total equity and liabilities10/49€267k
Equity10/15€-718k
Contributions10/11€86k
Profit (loss) carried forward14€-804k
Amounts payable17/49€985k
Amounts payable after more than one year17€741k
Financial debts170/4€741k
Amounts payable within one year42/48€83k
Trade debts44€3k
Suppliers440/4€3k
Other amounts payable47/48€80k
Accrued charges and deferred income492/3€161k
Income statement
Code2023
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€88k
Other operating charges640/8€411
Gross operating margin9900€-11k
Operating profit (loss)9901€-100k
Financial charges65/66B€17k
Recurring financial charges65€17k
Profit (loss) for the period before taxes9903€-117k
Profit (loss) for the period9904€-117k
Profit (loss) for the period to be appropriated9905€-117k
Appropriation of the result
Profit (loss) to be appropriated9906€-804k
Profit (loss) brought forward from the previous period14P€-687k
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
20-01
Bankruptcy
Bankruptcy closure (insufficient assets)
Ondernemingsrechtbank Leuven · VESALIUS MEDICAL TECHNOLOGIES BV PERSSTRAAT 20, 3320 HOEGAARDEN · event 15-01-2026
2024
16-10
Bankruptcy
Opening
Ondernemingsrechtbank Leuven · VESALIUS MEDICAL TECHNO- LOGIES BV PERSSTRAAT 20, 3320 HOEGAARDEN · event 10-10-2024
09-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
SignalNBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Insolvency mandates
1 mandate| Role | Name | Tenure |
|---|---|---|
| Curator | STEVEN VERBEKE OLV Broedersstraat 3, 3300 TIENEN- |
10-10-2024 → present |